Cortisone

ATC code H02AB10

Also known as: Cortison, Kortizon, Cortisone Acetate

Key facts
Active substance
Cortisone
Drug class
Glucocorticoid
ATC code
H02AB10
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-10-29

Key facts

Cortisone (as cortisone acetate) is a glucocorticoid. Per the US prescribing information, it is used for adrenocortical insufficiency and many rheumatic, allergic, dermatologic and collagen diseases.

What it is used for

  • Endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice), congenital adrenal hyperplasia, nonsuppurative thyroiditis, hypercalcemia associated with cancer
  • Rheumatic disorders as short-term adjunctive therapy, e.g. rheumatoid and psoriatic arthritis, ankylosing spondylitis, acute gouty arthritis, bursitis
  • Collagen diseases such as systemic lupus erythematosus, acute rheumatic carditis, dermatomyositis
  • Severe dermatologic diseases (e.g. pemphigus, severe erythema multiforme, severe psoriasis) and severe allergic states
  • Further indications, including eye diseases, see the full prescribing information

Dosing

  • Individualize according to the disease and the patient's response
  • Initial dose 25 to 300 mg a day; less severe diseases may need less than 25 mg, severe diseases more than 300 mg
  • After a favorable response, reduce in small steps to the lowest effective maintenance dose
  • During stress (e.g. surgery, infection, trauma) a temporary dose increase may be needed
  • After more than a few days of treatment, usually withdraw gradually

Contraindications

  • Systemic fungal infections
  • Hypersensitivity to this product

Important warnings

  • Immunosuppression with increased risk of infection by any pathogen; infections can be severe and fatal; latent tuberculosis may reactivate
  • Varicella and measles can be serious or fatal in non-immune patients; avoid exposure
  • Hepatitis B virus reactivation can occur; screen for hepatitis B before immunosuppressive treatment
  • Secondary adrenocortical insufficiency with too rapid withdrawal, which may persist for months
  • Live virus vaccines are contraindicated with immunosuppressive doses
  • Psychic derangements from euphoria and insomnia to severe depression and psychosis

Side effects

  • Sodium and fluid retention, potassium loss, hypertension, heart failure in susceptible patients
  • Muscle weakness, steroid myopathy, osteoporosis, vertebral compression fractures, aseptic necrosis, tendon rupture
  • Peptic ulcer with possible perforation and hemorrhage, pancreatitis
  • Impaired wound healing, thin fragile skin
  • Cushingoid state, growth suppression in children, decreased carbohydrate tolerance, menstrual irregularities
  • Convulsions, increased intracranial pressure; with prolonged use cataracts and glaucoma

Interactions

  • Live vaccines: contraindicated with immunosuppressive doses; response to inactivated vaccines may be absent
  • Aspirin: use cautiously with corticosteroids in hypoprothrombinemia

Pregnancy and breastfeeding

  • No adequate human studies; weigh the benefits against possible hazards to mother and fetus
  • Observe infants of mothers given substantial doses for hypoadrenalism; mothers on pharmacologic doses should not nurse

Summary of the official product information, written with AI on 2026-10-29. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

This product has no separate US patient information.

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Brand names in 3 more European countries
Italy
Cortone Acetato
Netherlands
Cortisonacetaat Teva
Norway
Cortison

EMA – Article 57 product data (EU/EEA), 2026-10-29

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Related calculators

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Cortisone Acetate (Chartwell RX, LLC) – Prescribing Information, 2025-06-06. DailyMed (NLM), 2026-10-29. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc158d11-f356-4696-8b73-5d2681dcbcf2
  2. Wikidata (CC0): ATC H02AB.

Editorial: Medelix editorial team · last updated 2026-10-29 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.